Showing 8,941 - 8,960 results of 32,496 for search '(( 50 ((teer decrease) OR (((mean decrease) OR (a decrease)))) ) OR ( e point decrease ))', query time: 1.15s Refine Results
  1. 8941
  2. 8942
  3. 8943

    Discovery of 2‑Ethoxy-5-isobutyramido‑<i>N</i>‑1-substituted Benzamide Derivatives as Selective Kv2.1 Inhibitors with In Vivo Neuroprotective Effects by Jie Zhou (28945)

    Published 2023
    “…In this work, a series of novel benzamide derivatives were designed and synthesized as Kv2.1 inhibitors, and extensive structure–activity relationships led to highly potent and selective Kv2.1 inhibitors having IC<sub>50</sub> values of 10<sup>–8</sup> M. …”
  4. 8944

    Discovery of 2‑Ethoxy-5-isobutyramido‑<i>N</i>‑1-substituted Benzamide Derivatives as Selective Kv2.1 Inhibitors with In Vivo Neuroprotective Effects by Jie Zhou (28945)

    Published 2023
    “…In this work, a series of novel benzamide derivatives were designed and synthesized as Kv2.1 inhibitors, and extensive structure–activity relationships led to highly potent and selective Kv2.1 inhibitors having IC<sub>50</sub> values of 10<sup>–8</sup> M. …”
  5. 8945

    Discovery of 2‑Ethoxy-5-isobutyramido‑<i>N</i>‑1-substituted Benzamide Derivatives as Selective Kv2.1 Inhibitors with In Vivo Neuroprotective Effects by Jie Zhou (28945)

    Published 2023
    “…In this work, a series of novel benzamide derivatives were designed and synthesized as Kv2.1 inhibitors, and extensive structure–activity relationships led to highly potent and selective Kv2.1 inhibitors having IC<sub>50</sub> values of 10<sup>–8</sup> M. …”
  6. 8946
  7. 8947
  8. 8948
  9. 8949
  10. 8950
  11. 8951
  12. 8952
  13. 8953

    Novel Antagonist of the Type 2 Lysophosphatidic Acid Receptor (LPA<sub>2</sub>), UCM-14216, Ameliorates Spinal Cord Injury in Mice by Nora Khiar-Fernández (8130210)

    Published 2022
    “…Inhibition of the type 2 lysophosphatidic acid receptor (LPA<sub>2</sub>) has recently emerged as a new potential pharmacological approach to decrease SCI-associated damage. …”
  14. 8954

    Novel Antagonist of the Type 2 Lysophosphatidic Acid Receptor (LPA<sub>2</sub>), UCM-14216, Ameliorates Spinal Cord Injury in Mice by Nora Khiar-Fernández (8130210)

    Published 2022
    “…Inhibition of the type 2 lysophosphatidic acid receptor (LPA<sub>2</sub>) has recently emerged as a new potential pharmacological approach to decrease SCI-associated damage. …”
  15. 8955
  16. 8956
  17. 8957
  18. 8958
  19. 8959
  20. 8960